When was Corden Pharma founded?

Corden Pharma was founded in 2006.

Where is Corden Pharma located?

Corden Pharma is headquartered in Plankstadt, Germany. It is registered at Boulder, Colorado.

How many employees does Corden Pharma have?

As of Aug 31, 2026, the latest employee count at Corden Pharma is 1947.

Where does Corden Pharma rank among its competitors?

Corden Pharma ranks 30th amongst 384 active competitors, of which 15 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Almac Group, which secured $417K in Sep, 2022.

Who are the top competitors of Corden Pharma?

Corden Pharma's top competitors include Concord Biotech, Biophore and Almac Group. Among them, Almac Group secured the most recent funding round in September, 2022.

Corden Pharma - 2026 Company Profile, Funding & Competitors

Corden Pharma is an acquired company based in Plankstadt (Germany), founded in 2006. It operates as a CDMO offering its services for small molecules, peptides, lipids and carbohydrates. The company has 384 active competitors, including 15 funded and 91 that have exited. Its top competitors include companies like Concord Biotech, Biophore and Almac Group.

Company Details

CordenPharma is a full-service partner in the Contract Development and Manufacturing (CDMO) of APIs, Drug Products and associated Packaging, Logistics, and Clinical Supply Services. Through their network of fully-inspected cGMP facilities across Europe and the US which are organised under six technology platforms namely, Antibiotics, Highly Potent & Oncology Products, Small Molecules, Peptides/Lipids & Carbohydrates, Injectables, Fermentation & Enzymes they offer product development and manufacturing services. The company has facilities in Italy, US, Germany, France, Belgium and Switzerland. CordenPharma claims that it can translate complex ideas at any stage of development into high-value products. CordenPharma specialises in the development of oncology drugs(Sterile and Oral dosage forms, including HPAPIs) and fermentation based small molecules.

Website: cordenpharma.com
Social
Registered Address: Boulder, Colorado

Key Metrics

Founded Year

2006

Location

Plankstadt, Germany

Stage

Acquired

Investors

University Venture Fund

Ranked

30^th among 384 active competitors

Employee Count

1,947 as on Aug 31, 2026

Investment & Acquisitions

AmbioPharm & 1 more

Similar Companies

Concord Biotech & 429 more

Exit Details

Acquired by Astorg Partners (May 02, 2022)

View Corden Pharma's full profile

Corden Pharma is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Corden Pharma Switzerland LLC CIN: 446498 , Switzerland, Active	Feb 13, 2024	-	-	-
Corden Pharma GmbH CIN: B1601_HRB709385 , Germany, Active	May 20, 2010	-	-
Corden Pharma International GmbH CIN: B1601_HRB701567 , Germany, Active	Jan 15, 2007	-	-
Corden Pharma International GmbH CIN: HRB701567 , Germany, Active	Jan 14, 2007	-	-
CORDEN PHARMA COLORADO, INC. CIN: 840631676 , United States, Active	Dec 26, 999	-	677 (As on Dec 31, 2024)	-

Corden Pharma got acquired by Astorg Partners on May 02, 2022 at an acquisition amount of $*****.

Click here to take a look at Corden Pharma's acquisition in detail

Corden Pharma is a funded company. Corden Pharma has 1 institutional investor.

View details of Corden Pharma's funding rounds and investors

Corden Pharma's employee count trend

Corden Pharma has 1,947 employees as of Aug 26. Here is Corden Pharma's employee count trend over the years:

Uncover Corden Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Corden Pharma include Concord Biotech, Biophore and Almac Group. Here is the list of Top 10 competitors of Corden Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Concord Biotech 1984, Ahmedabad (India), Public	CDMO focused on manufacturing API	$11.3M	Quadria Capital, Helix Investments & 18 others	69/100
2nd	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	62/100
3rd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	57/100
4th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
5th	Jagsonpal 1964, Delhi (India), Public	Traditional company manufacturing bulk drugs and finished formulations	-	Convergent, Aresko	53/100
6th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	53/100
7th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
8th	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$16.8M	Zephyr Management, Zephyr Peacock & 39 others	51/100
9th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	51/100
10th	Asymchem 1995, Morrisville (United States), Public	CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally	-	Hillhouse, HSG & 5 others	50/100
30th	Corden Pharma 2006, Plankstadt (Germany), Acquired	CDMO offering its services for small molecules, peptides, lipids and carbohydrates	-	University Venture Fund	46/100